You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Viral Envelope Proteins

Showing 1 - 25 of 7,319
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV-1-infection Trial in London (ConM SOSIP, EDC ConM SOSIP, ConS UFO)

Active, not recruiting
  • HIV-1-infection
  • ConM SOSIP
  • +4 more
  • London, United Kingdom
    NIHR Imperial Clinical Resarch Facility
Jul 25, 2022

Virus Diseases Trial in London (ConM SOSIP 50 ug and ConS UFO 50 ug, Mos3.1 100 ug, Mos3.2 100 ug)

Active, not recruiting
  • Virus Diseases
  • ConM SOSIP 50 ug and ConS UFO 50 ug
  • +4 more
  • London, Please Select..., United Kingdom
    NIHR Imperial Clinical Research Facility
Jul 25, 2022

A Multicenter, Randomized, Placebo-Controlled, Double-Blind

Withdrawn
  • HIV Infections
    • (no location specified)
    Oct 27, 2021

    HIV Trial in Rochester, Seattle (gp160 Vaccine (Immuno-AG), rgp120/HIV-1IIIB, rgp120/HIV-1MN)

    Completed
    • HIV Infections
    • gp160 Vaccine (Immuno-AG)
    • +4 more
    • Rochester, New York
    • +1 more
    Oct 28, 2021

    HIV-1-infection Trial in Amsterdam (ConM SOSIP.v7 gp140, adjuvanted with MPLA liposomes)

    Active, not recruiting
    • HIV-1-infection
    • ConM SOSIP.v7 gp140, adjuvanted with MPLA liposomes
    • Amsterdam, Noord-Holland, Netherlands
      Amsterdam University Medical Centers, location AMC
    Jan 31, 2023

    From COVID-19 Convalescents Previously Hospitalized to Identify

    Completed
    • Identify the Viral Epitopes of Memory CD8 T Cells From Individuals That Have Recovered From SARS-CoV-2 Infection
    • Determine Which SARS-CoV-2 Proteins Are Frequently Recognized by T Cells in Patients With Varying HLA Types
      • New Orleans, Louisiana
      • +1 more
      Apr 12, 2021

      HIV Trial in Seattle (HIVAC-1e, gp160 Vaccine (MicroGeneSys))

      Completed
      • HIV Infections
      • HIVAC-1e
      • gp160 Vaccine (MicroGeneSys)
      • Seattle, Washington
        Children's Hospital & Medical Center / Seattle ACTU
      Oct 26, 2021

      HIV Trial in Nashville, Seattle (HIVAC-1e, gp160 Vaccine (MicroGeneSys))

      Completed
      • HIV Infections
      • HIVAC-1e
      • gp160 Vaccine (MicroGeneSys)
      • Nashville, Tennessee
      • +1 more
      Oct 26, 2021

      Hepatitis B, Chronic Trial in Worldwide (ChAd155-hIi-HBV low dose formulation, ChAd155-hIi-HBV high dose formulation,

      Recruiting
      • Hepatitis B, Chronic
      • ChAd155-hIi-HBV low dose formulation
      • +6 more
      • Antwerpen, Belgium
      • +35 more
      Jan 28, 2022

      HIV Trial in United States (TBC-3B Vaccine, Smallpox Vaccine)

      Completed
      • HIV Infections
      • TBC-3B Vaccine
      • Smallpox Vaccine
      • Saint Louis, Missouri
      • +4 more
      Oct 27, 2021

      Respiratory Syncytial Virus Infections Trial in Worldwide (RSV (GSK3389245A) low dose formulation vaccine, RSV (GSK3389245A)

      Completed
      Has Results
      • Respiratory Syncytial Virus Infections
      • RSV (GSK3389245A) low dose formulation vaccine
      • +3 more
      • Anaheim, California
      • +23 more
      Sep 28, 2021

      HIV Trial in Puerto Rico, United States (rgp120/HIV-1MN, rgp120/HIV-1 SF-2, gp160 Vaccine (MicroGeneSys))

      Completed
      • HIV Infections
      • rgp120/HIV-1MN
      • +2 more
      • Long Beach, California
      • +33 more
      Oct 27, 2021

      HIV, HIV Seronegativity Trial in Rochester, Nashville, Seattle (MTP-PE/MF59, Env 2-3)

      Completed
      • HIV Infections
      • HIV Seronegativity
      • MTP-PE/MF59
      • Env 2-3
      • Rochester, New York
      • +2 more
      Oct 28, 2021

      SARS-CoV-2 Infection, COVID-19, Coronavirus Trial in Marseille, Nîmes (eBAM Cov Testing)

      Not yet recruiting
      • SARS-CoV-2 Infection
      • +2 more
      • eBAM Cov Testing
      • Marseille, France
      • +1 more
      Oct 23, 2023

      Respiratory Viral Infection Trial (Nasal Spray)

      Not yet recruiting
      • Respiratory Viral Infection
      • Nasal Spray
      • (no location specified)
      Nov 19, 2022

      HIV Trial in Rochester (HIVAC-1e, gp160 Vaccine (MicroGeneSys))

      Completed
      • HIV Infections
      • HIVAC-1e
      • gp160 Vaccine (MicroGeneSys)
      • Rochester, New York
        Univ. of Rochester AVEG
      Oct 26, 2021

      HIV Trial in Rochester (MTP-PE/MF59, Env 2-3)

      Completed
      • HIV Infections
      • MTP-PE/MF59
      • Env 2-3
      • Rochester, New York
        Univ. of Rochester AVEG
      Oct 27, 2021

      Waxing and Waning of Serum SARS CoV-2-IgG Level in COVID-19

      Recruiting
      • Covid19
      • Plasma IgG levels
      • Lahore, Punjab, Pakistan
      • +1 more
      Feb 12, 2022

      Healthy Trial (763SIP8/MPLA-5 vaccine)

      Not yet recruiting
      • Healthy
      • 763SIP8/MPLA-5 vaccine
      • (no location specified)
      Mar 15, 2023

      Cellular and Humoral Immunity to COVID-19 in Moscow Residents

      Recruiting
      • Covid19
      • Respiratory Viral Infection
      • SARS-CoV-2 specific IgM and IgG detection
      • +2 more
      • Moscow, Russian Federation
        Clinical City Hospital named after I.V. Davydovsky of Moscow Dep
      May 21, 2021

      Non-Genital Warts Trial (garlic extract (15%) solution, topical chlorhexidine (2%) solution, Saline)

      Not yet recruiting
      • Non-Genital Warts
      • garlic extract (15%) solution
      • +2 more
      • (no location specified)
      Oct 13, 2023

      Respiratory Tract Infections, Corona Virus Infection Trial in Vancouver (Nitric Oxide 0.5 % / Nitrogen 99.5 % Gas for

      Terminated
      • Respiratory Tract Infections
      • Corona Virus Infection
      • Nitric Oxide 0.5 % / Nitrogen 99.5 % Gas for Inhalation
      • Vancouver, British Columbia, Canada
        Nitric Solutions-Mobile Unit
      Jul 12, 2021

      SARS-CoV Infection Trial (Ozonized oil (HOO)

      Withdrawn
      • SARS-CoV Infection
      • Ozonized oil (HOO
      • (no location specified)
      Jan 11, 2022

      HIV-1-infection Trial in Umlazi (Vesatolimod, VRC07523LS, CAP256V2LS)

      Recruiting
      • HIV-1-infection
      • Umlazi, South Africa
        FRESH Clinical Research Site: Females Rising through Education,
      Jan 4, 2023

      HIV Infection Trial in Cleveland (Recombinant Interleukin-2)

      Terminated
      Has Results
      • HIV Infection
      • Recombinant Interleukin-2
      • Cleveland, Ohio
        AIDS Clinical Trials Unit
      Sep 1, 2022